Risk factors and outcomes of definite or clinical idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation

References

• Afessa B, Litzow MR, Tefferi A. Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;28(5):425–434.
   PubMed Web of Science ®Google Scholar
• Huisman C, van der Straaten HM, Canninga-van Dijk MR, et al. Pulmonary complications after T-cell-depleted allogeneic stem cell transplantation: low incidence and strong association with acute graft-versus-host disease. Bone Marrow Transplant. 2006;38(8):561–566.
   PubMed Web of Science ®Google Scholar
• Broglie L, Fretham C, Al-Seraihy A, et al. Pulmonary complications in pediatric and adolescent patients following allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2019;25(10):2024–2030.
   PubMed Web of Science ®Google Scholar
• Fukuda T, Hackman RC, Guthrie KA, et al. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood. 2003;102(8):2777–2785.
   PubMed Web of Science ®Google Scholar
• Sano H, Kobayashi R, Iguchi A, et al. Risk factor analysis of idiopathic pneumonia syndrome after allogeneic hematopoietic SCT in children. Bone Marrow Transplant. 2014;49(1):38–41.
   PubMed Web of Science ®Google Scholar
• Wenger DS, Triplette M, Crothers K, et al. Incidence, risk factors, and outcomes of idiopathic pneumonia syndrome after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2020;26(2):413–420.
   PubMed Web of Science ®Google Scholar
• Zhu KE, Hu JY, Zhang T, et al. Incidence, risks, and outcome of idiopathic pneumonia syndrome early after allogeneic hematopoietic stem cell transplantation. Eur J Haematol. 2008;81(6):461–466.
   PubMed Web of Science ®Google Scholar
• Panoskaltsis-Mortari A, Griese M, Madtes DK, et al. An official American thoracic society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome. Am J Respir Crit Care Med. 2011;183(9):1262–1279.
   PubMed Web of Science ®Google Scholar
• Seo S, Renaud C, Kuypers JM, et al. Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies. Blood. 2015;125(24):3789–3797.
   PubMed Web of Science ®Google Scholar
• Kurihara T, Hayashi J, Ito A, et al. CMV antigenemia assay using indirect ALP-immunostaining in bone marrow transplant recipients. Transplant Proc. 1996;28(3):1750–1753.
   PubMed Web of Science ®Google Scholar
• Filipovich AH, Weisdorf D, Pavletic S, et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11(12):945–956.
   PubMed Web of Science ®Google Scholar
• Giralt S, Ballen K, Rizzo D, et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant. 2009;15(3):367–369.
   PubMed Web of Science ®Google Scholar
• Akahane K, Shirai K, Wakatsuki M, et al. Dosimetric evaluation of ovaries and pelvic bones associated with clinical outcomes in patients receiving total body irradiation with ovarian shielding. J Radiat Res. 2021;62(5):918–925.
   PubMed Web of Science ®Google Scholar
• Oshima K, Kanda Y, Nakasone H, et al. Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level. Am J Hematol. 2008;83(3):226–232.
   PubMed Web of Science ®Google Scholar
• Kimura SI, Nakamura Y, Kawamura M, et al. Association of the areas over and under the lymphocyte curve with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2021;23(1):e13460.
   PubMed Web of Science ®Google Scholar
• Takeshita J, Kimura SI, Nakasone H, et al. Association between the kinetics of cytomegalovirus reactivation in terms of the area under the curve of cytomegalovirus antigenemia and non-relapse mortality after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2021;23(5):e13715.
   PubMed Web of Science ®Google Scholar
• Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15(6):825–828.
   PubMed Web of Science ®Google Scholar
• Petersdorf EW, Hansen JA, Martin PJ, et al. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med. 2001;345(25):1794–1800.
   PubMed Web of Science ®Google Scholar
• Fuji S, Nakamura F, Hatanaka K, et al. Peripheral blood as a preferable source of stem cells for salvage transplantation in patients with graft failure after cord blood transplantation: a retrospective analysis of the registry data of the Japanese Society for Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2012;18(9):1407–1414.
   PubMed Web of Science ®Google Scholar
• Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48(3):452–458.
   PubMed Web of Science ®Google Scholar
• Altmann T, Slack J, Slatter MA, et al. Endothelial cell damage in idiopathic pneumonia syndrome. Bone Marrow Transplant. 2018;53(4):515–518.
   PubMed Web of Science ®Google Scholar
• Seo S, Yu J, Jenkins IC, et al. Diagnostic and prognostic plasma biomarkers for idiopathic pneumonia syndrome after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2018;24(4):678–686.
   PubMed Web of Science ®Google Scholar
• Piñana JL, Martino R, Barba P, et al. Pulmonary function testing prior to reduced intensity conditioning allogeneic stem cell transplantation in an unselected patient cohort predicts posttransplantation pulmonary complications and outcome. Am J Hematol. 2012;87(1):9–14.
   PubMed Web of Science ®Google Scholar
• Duque-Afonso J, Ihorst G, Waterhouse M, et al. Impact of lung function on bronchiolitis obliterans syndrome and outcome after allogeneic hematopoietic cell transplantation with reduced-intensity conditioning. Biol Blood Marrow Transplant. 2018;24(11):2277–2284.
   PubMed Web of Science ®Google Scholar
• Armand P, Kim HT, Rhodes J, et al. Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation. Biol Blood Marrow Transplant. 2011;17(6):852–860.
   PubMed Web of Science ®Google Scholar
• Salmi A, Holmström M, Toiviainen-Salo S, et al. Iron overload after allogeneic stem cell transplantation in children with acute lymphoblastic leukemia. Pediatr Transplant. 2020;24(8):e13846.
   PubMed Web of Science ®Google Scholar
• Nakane T, Nakamae H, Kamoi H, et al. Prognostic value of serum surfactant protein D level prior to transplant for the development of bronchiolitis obliterans syndrome and idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2008;42(1):43–49.
   PubMed Web of Science ®Google Scholar